Validation of a neutralizing antibody (NAb) assay with an extended reportable range for entranacogene dezaparvovec, an adeno-associated virus serotype 5 (AAV5)-based gene therapy for adult hemophilia B (ISTH 2024)

resources center
Collected experience from groundbreaking researchers, scientists, data experts, business innovators and studies. And a convenient hub for downloading our latest service offerings from each stage of the drug development journey.
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster
eBook
Download eBook